Pharmaceutical

Roche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurch

Partnerships, mergers, business combinations, and acquisitions could all be on the horizon for the biotech.

Jul 25, 2023 - 20:00
Roche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurch
Partnerships, mergers, business combinations, and acquisitions could all be on the horizon for the biotech.
Read the original article

Tags:

Previous Article

Statins reduce cardiovascular risk in people living with HIV, new global study f...

Next Article

Astellas and PeptiDream enter protein degrader discovery deal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Preventing health care violence in the ER requires moving from safety to security

Opinion: Preventing health care violence in the ER requ...

Jan 10, 2024

Women face host of disadvantages in cancer prevention and care, report finds

Women face host of disadvantages in cancer prevention a...

Sep 26, 2023

ProMED issues ultimatum to striking moderators, as questions about site’s future persist

ProMED issues ultimatum to striking moderators, as ques...

Aug 29, 2023